+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hyoscine Market by Brand Type, Application, End User, Dosage Form, Distribution Channel - Global Forecast to 2030- Product Image
Hyoscine Market by Brand Type, Application, End User, Dosage Form, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Hyoscine Market by Brand Type, Application, End User, Dosage Form, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674584
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Hyoscine market, valued at USD 460.41 million in 2024, is on a trajectory of significant growth, projected to reach USD 604.56 million by 2030 at a CAGR of 4.64%. As Hyoscine solidifies its role in modern therapeutics, it is particularly impactful in treating gastrointestinal disorders and motion sickness, thanks to its potent anticholinergic properties. This market research report provides critical insights into the evolving landscape, making it an indispensable tool for strategic planning and competitive advantage.

Setting the Stage for Hyoscine’s Role in Modern Therapeutics

Hyoscine has firmly established itself as a crucial element in therapeutic protocols for managing gastrointestinal and vestibular disturbances. Its diverse dosage forms accommodate varied patient needs, enhancing compliance in hospital and at-home care. Technological advances have broadened its clinical applications through improved bioavailability and patient adherence.

The comprehensive analysis within this report distills pivotal insights from extensive research, highlighting the market's trajectory. Stakeholders in pharmaceutical development and healthcare delivery can leverage this report to identify opportunities and address potential challenges within this evolving market.

Unprecedented Shifts Reshaping the Hyoscine Landscape

The Hyoscine market is experiencing transformative shifts due to innovative technologies and changing regulatory landscapes. Novel transdermal and precision dosing platforms are enhancing clinical outcomes. Regulatory frameworks are evolving, demanding higher quality standards, which has prompted strategic collaborations to ensure growth and patient safety.

The integration of digital health solutions is revolutionizing patient engagement, facilitating at-home administration, and improving adherence, lowering hospital readmission rates, and enhancing long-term treatment effectiveness.

Navigating the Ripple Effects of 2025 US Tariffs on Hyoscine

The 2025 US tariffs have impacted the global Hyoscine supply chain, amplifying import duties and material costs. This has driven manufacturers to localize supply chains and engage in strategic vertical integrations to reduce dependencies. These adaptive strategies are enhancing supply chain transparency and maintaining market competitiveness.

Investments in process efficiency and sustainable production are minimizing the reliance on imported precursors, underscoring the market's resilience amid trade disruptions.

Decoding Market Segmentation to Unlock Hyoscine Opportunities

Market segmentation analysis reveals promising avenues for Hyoscine's growth. Branded formulations maintain premium market positioning through innovative delivery methods, while generics grow by meeting cost-sensitive demands. Gastrointestinal disorders dominate therapeutic applications, with motion sickness providing seasonal demand spikes.

End-user insights show clinics, home care, and hospitals as key channels, each influencing dosage form preferences. Distribution through diverse channels, such as hospital pharmacies and online portals, highlights the importance of tailored strategies to meet unique stakeholder needs.

Regional Dynamics Driving Hyoscine Adoption Globally

Regional factors significantly influence Hyoscine's market growth. In Americas, strong healthcare infrastructures facilitate innovative format adoption, while Latin America holds potential in hospital protocols. European regulatory harmonization aids fast market entry, and Middle East investments boost motion sickness products. Asia-Pacific presents dual dynamics with mature and emerging markets requiring differentiated approaches to fulfill local demand.

Competitive Landscape and Leading Innovators in Hyoscine

The Hyoscine market is competitive, featuring established giants and nimble biotech firms. Multinational companies leverage their R&D and distribution assets for premium product positioning, while generics capitalize on cost efficiencies. Strategic alliances and cutting-edge innovations, especially in transdermal technologies, are carving new market pathways.

Strategic Imperatives for Industry Leaders to Capitalize on Hyoscine Trends

Industry leaders should balance portfolios between premium and value segments, using life cycle extensions and capacity expansions to navigate market complexities. Partnerships with technology providers accelerate market entries into high-growth areas, like transdermal patches. Regional customization and digital health platform integration further differentiate products, enhancing strategic positioning.

Robust Methodological Framework Underpinning Market Insights

This market analysis leverages a multi-tiered research approach, combining executive interviews, secondary data, and competitive benchmarks for robust insights. This methodology ensures the accuracy and relevance of data, providing stakeholders with a reliable guide to the Hyoscine landscape.

Key Takeaways from This Report

  • Hyoscine’s market is poised for expansion due to technological innovation and strategic partnerships.
  • The 2025 US tariffs have prompted supply chain localization and efficiency improvements.
  • Understanding market segmentation unveils critical growth levers.
  • Regional strategies are essential for successful market penetration and adoption.

Conclusion

This report offers a strategic roadmap to seize emerging opportunities, mitigate risks, and enhance decision-making in the Hyoscine market. Insights highlight the importance of agility, collaboration, and data-driven strategies to thrive in today’s competitive landscape.

Market Segmentation & Coverage

This research report categorizes to forecast revenues and trends in several sub-segments, including:

  • Brand Type: Branded, Generic
  • Application: Gastrointestinal Disorders, Motion Sickness
  • End User: Clinics, Home Care, Hospitals
  • Dosage Form: Injectable Solution, Oral Tablets, Transdermal Patch
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

This research report categorizes to forecast revenues in various regions:

  • Americas: United States, Canada, Mexico, Brazil, Argentina
  • Europe, Middle East & Africa: Including UK, Germany, UAE, Nigeria
  • Asia-Pacific: Including China, India, Japan, Australia

This research also considers major players in the market, such as:

  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hyoscine Market, by Brand Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Hyoscine Market, by Application
9.1. Introduction
9.2. Gastrointestinal Disorders
9.3. Motion Sickness
10. Hyoscine Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care
10.4. Hospitals
11. Hyoscine Market, by Dosage Form
11.1. Introduction
11.2. Injectable Solution
11.3. Oral Tablets
11.4. Transdermal Patch
12. Hyoscine Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.2.1. Government Hospital Pharmacy
12.2.2. Private Hospital Pharmacy
12.3. Online Pharmacy
12.3.1. Mobile App
12.3.2. Web Only Portal
12.4. Retail Pharmacy
12.4.1. Chain Pharmacy
12.4.2. Independent Pharmacy
13. Americas Hyoscine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Hyoscine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Hyoscine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novartis AG
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.3. Viatris Inc.
16.3.4. Dr. Reddy’s Laboratories Ltd.
16.3.5. Sun Pharmaceutical Industries Ltd.
16.3.6. Hikma Pharmaceuticals PLC
16.3.7. Sandoz International GmbH
16.3.8. Glenmark Pharmaceuticals Ltd.
16.3.9. Wockhardt Ltd.
16.3.10. Pfizer Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HYOSCINE MARKET MULTI-CURRENCY
FIGURE 2. HYOSCINE MARKET MULTI-LANGUAGE
FIGURE 3. HYOSCINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HYOSCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HYOSCINE MARKET SIZE, BY BRAND TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HYOSCINE MARKET SIZE, BY BRAND TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HYOSCINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HYOSCINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HYOSCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HYOSCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HYOSCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HYOSCINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HYOSCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HYOSCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HYOSCINE MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HYOSCINE MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HYOSCINE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HYOSCINE MARKET SIZE, BY MOTION SICKNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HYOSCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HYOSCINE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HYOSCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HYOSCINE MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HYOSCINE MARKET SIZE, BY ORAL TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HYOSCINE MARKET SIZE, BY TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HYOSCINE MARKET SIZE, BY GOVERNMENT HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HYOSCINE MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HYOSCINE MARKET SIZE, BY MOBILE APP, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HYOSCINE MARKET SIZE, BY WEB ONLY PORTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HYOSCINE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HYOSCINE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. CANADA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 52. CANADA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. CANADA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. CANADA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 55. CANADA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CANADA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 57. CANADA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 58. CANADA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 59. MEXICO HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. MEXICO HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. MEXICO HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 63. MEXICO HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. MEXICO HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 65. MEXICO HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 100. GERMANY HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 101. GERMANY HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. GERMANY HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. GERMANY HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 104. GERMANY HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. GERMANY HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 106. GERMANY HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 107. GERMANY HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 108. FRANCE HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 109. FRANCE HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. FRANCE HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. FRANCE HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 112. FRANCE HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FRANCE HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 114. FRANCE HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 115. FRANCE HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 124. ITALY HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 125. ITALY HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. ITALY HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. ITALY HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 128. ITALY HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 130. ITALY HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 131. ITALY HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 132. SPAIN HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 133. SPAIN HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SPAIN HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. SPAIN HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 136. SPAIN HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. SPAIN HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 138. SPAIN HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 139. SPAIN HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 148. SAUDI ARABIA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 149. SAUDI ARABIA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 156. SOUTH AFRICA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 164. DENMARK HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 165. DENMARK HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. DENMARK HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. DENMARK HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 168. DENMARK HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. DENMARK HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 170. DENMARK HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 171. DENMARK HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 180. QATAR HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 181. QATAR HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. QATAR HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. QATAR HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 184. QATAR HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. QATAR HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 186. QATAR HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 187. QATAR HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 188. FINLAND HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 189. FINLAND HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. FINLAND HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. FINLAND HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 192. FINLAND HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. FINLAND HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 194. FINLAND HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 195. FINLAND HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 196. SWEDEN HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 197. SWEDEN HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 212. EGYPT HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 213. EGYPT HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. EGYPT HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. EGYPT HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 216. EGYPT HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. EGYPT HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 218. EGYPT HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 219. EGYPT HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 220. TURKEY HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. TURKEY HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. TURKEY HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 224. TURKEY HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. TURKEY HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 226. TURKEY HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 227. TURKEY HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 228. ISRAEL HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 236. NORWAY HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 237. NORWAY HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. NORWAY HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. NORWAY HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 240. NORWAY HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. NORWAY HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 242. NORWAY HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 243. NORWAY HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 244. POLAND HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 245. POLAND HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. POLAND HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. POLAND HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 248. POLAND HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. POLAND HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 250. POLAND HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 251. POLAND HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 252. SWITZERLAND HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 269. CHINA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 270. CHINA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. CHINA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. CHINA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 273. CHINA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. CHINA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 275. CHINA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 276. CHINA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 277. INDIA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 278. INDIA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. INDIA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. INDIA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 281. INDIA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. INDIA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 283. INDIA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 284. INDIA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 285. JAPAN HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 286. JAPAN HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. JAPAN HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. JAPAN HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 289. JAPAN HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. JAPAN HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 291. JAPAN HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 292. JAPAN HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 293. AUSTRALIA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 309. INDONESIA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 317. THAILAND HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 318. THAILAND HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. THAILAND HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. THAILAND HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 321. THAILAND HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. THAILAND HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 323. THAILAND HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 324. THAILAND HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 325. PHILIPPINES HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 333. MALAYSIA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 334. MALAYSIA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 335. MALAYSIA HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 341. SINGAPORE HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 342. SINGAPORE HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 343. SINGAPORE HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 346. SINGAPORE HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 349. VIETNAM HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 350. VIETNAM HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 351. VIETNAM HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 352. VIETNAM HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 353. VIETNAM HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 354. VIETNAM HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 355. VIETNAM HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 356. VIETNAM HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 357. TAIWAN HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2030 (USD MILLION)
TABLE 358. TAIWAN HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 359. TAIWAN HYOSCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 360. TAIWAN HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 361. TAIWAN HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 362. TAIWAN HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 363. TAIWAN HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 364. TAIWAN HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 365. HYOSCINE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 366. HYOSCINE MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Hyoscine market report include:
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Hikma Pharmaceuticals PLC
  • Sandoz International GmbH
  • Glenmark Pharmaceuticals Ltd.
  • Wockhardt Ltd.
  • Pfizer Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 482.18 Million
Forecasted Market Value ( USD ) by 2030 $ 604.56 Million
Compound Annual Growth Rate4.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Hyoscine - Global Strategic Business Report - Product Image

Hyoscine - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Hyoscine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Hyoscine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 95 Pages
  • Global
From
Antispasmodics Drugs Market Report 2025 - Product Image

Antispasmodics Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Divalproex Sodium Market by Form, Distribution Channel, Indication, Route of Administration, Dosage Strength - Global Forecast to 2030 - Product Image

Divalproex Sodium Market by Form, Distribution Channel, Indication, Route of Administration, Dosage Strength - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Insomnia Pharmacological Treatment Market by Drug Class, Dosage Form, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Insomnia Pharmacological Treatment Market by Drug Class, Dosage Form, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From

About the Scopolamine Market

Scopolamine is a drug used to treat a variety of conditions related to the central nervous system. It is a muscarinic antagonist, meaning it blocks the action of the neurotransmitter acetylcholine. It is used to treat motion sickness, nausea, and vomiting, as well as to reduce the symptoms of Parkinson's disease. It is also used to treat irritable bowel syndrome and to reduce the symptoms of opioid withdrawal. Scopolamine is available in both oral and transdermal forms. Scopolamine is a widely used drug in the central nervous system drug market. It is used to treat a variety of conditions, and its availability in both oral and transdermal forms makes it a popular choice for many patients. It is also relatively inexpensive, making it an attractive option for those with limited budgets. Some companies in the scopolamine market include Novartis, Merck, Pfizer, and Mylan. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.